Literature DB >> 21119649

Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania.

Leonard J Paulozzi1, Daniel D Stier.   

Abstract

Drug overdose mortality nearly doubled in the United States from 1999 to 2004, with most of the increase due to prescription drug overdoses. Studying mortality rates in states that did not experience such increases may identify successful prescription overdose prevention strategies. We compared New York, a state that did not experience an overdose increase, with its neighbor, Pennsylvania. New York and Pennsylvania had prescription drug monitoring programs (PDMPs), but New York's PDMP was better funded and made use of serialized, tamperproof prescription forms. Per capita usage of the major prescription opioids in New York was two-thirds that of Pennsylvania. The drug overdose death rate in Pennsylvania was 1.6 times that of New York in 2006. Differences between New York and Pennsylvania might be due to the regulatory environment in New York State.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21119649     DOI: 10.1057/jphp.2010.27

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  8 in total

1.  Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings.

Authors:  N J Pauly; S Slavova; C Delcher; P R Freeman; J Talbert
Journal:  Drug Alcohol Depend       Date:  2018-01-11       Impact factor: 4.492

Review 2.  Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review.

Authors:  Nicholas B King; Veronique Fraser; Constantina Boikos; Robin Richardson; Sam Harper
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

3.  Factors Associated With County-Level Differences in U.S. Drug-Related Mortality Rates.

Authors:  Shannon M Monnat
Journal:  Am J Prev Med       Date:  2018-03-26       Impact factor: 5.043

4.  Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011.

Authors:  Corey S Davis; Matthew Pierce; Nabarun Dasgupta
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

5.  Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.

Authors:  Yuhua Bao; Yijun Pan; Aryn Taylor; Sharmini Radakrishnan; Feijun Luo; Harold Alan Pincus; Bruce R Schackman
Journal:  Health Aff (Millwood)       Date:  2016-06-01       Impact factor: 6.301

6.  Applying Farr's Law to project the drug overdose mortality epidemic in the United States.

Authors:  Salima Darakjy; Joanne E Brady; Charles J DiMaggio; Guohua Li
Journal:  Inj Epidemiol       Date:  2014-12-10

7.  Prescription drug monitoring and drug overdose mortality.

Authors:  Guohua Li; Joanne E Brady; Barbara H Lang; James Giglio; Hannah Wunsch; Charles DiMaggio
Journal:  Inj Epidemiol       Date:  2014-04-24

Review 8.  Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis.

Authors:  Joanne E Brady; Rebecca Giglio; Katherine M Keyes; Charles DiMaggio; Guohua Li
Journal:  Inj Epidemiol       Date:  2017-08-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.